Health care professionals’ awareness of, knowledge about and attitude to influenza vaccination

Alshammari, Thamir M.; Alfehaid, Lama; AlFraih, Joud K.; Aljadhey, Hisham

doi:10.1016/j.vaccine.2014.08.061

Cited by 62 publications

(98 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This was significantly lower than the 66.7% suggested in the study by Haffman et al [27]. In a study by Alshammari et al, the “fear of getting flu” was found to be the main reason for refusing the influenza vaccine [17]. In the present study, this figure was 24.4%.…”

Section: Discussioncontrasting

confidence: 78%

“…The lower rate of the misperception in the present study indicates their higher awareness. Majority of the HCPs believed that there was no live virus in the flu shot 82.8% of the HCPs believed that the influenza vaccination can prevent the influenza infection, whereas, in the study by Alshammari et al, only 71.43% of the HCPs believed such [17]. In the present research, 57.9% of the HCPs agreed with the vaccination of pregnant women against influenza.…”

Section: Discussioncontrasting

confidence: 53%

“…The physician’s vaccination rate was the lowest. The studies in Saudi Arabia identified similar result; the physician’s vaccination rate was relatively low as compared with other HCPs [17, 24]. According to Durando et al [5], being physician was independently accompanied with adherence to immunization against influenza.…”

Section: Discussionmentioning

confidence: 79%

See 2 more Smart Citations

Assessment of the belief and attitudes of Iranian healthcare personnel’s toward the influenza infection and influenza vaccination

Hosamirudsari

Kanavee

Ghanbari

et al. 2019

Journal of Preventive Medicine and Hygiene

View full text Add to dashboard Cite

Section: Discussioncontrasting

confidence: 78%

Section: Discussioncontrasting

confidence: 53%

See 1 more Smart Citation

Assessment of the belief and attitudes of Iranian healthcare personnel’s toward the influenza infection and influenza vaccination

Hosamirudsari

Kanavee

Ghanbari

et al. 2019

Journal of Preventive Medicine and Hygiene

View full text Add to dashboard Cite

“…Moreover, 20.1% of the HWCs were oblivious of the value of a vaccine in disease protection while 17.3% worried about the adverse effects of the vaccine (12). Another study was done in Saudi Arabia by Alshammari et al where they investigated the cause of low adoption of the influenza vaccine (13). It was realized that most of the HWCs (75%) were unaware of the vaccination guidelines developed by the Advisory Committee on Immunization Practices and Centre for Disease Control.…”

Section: Introductionmentioning

confidence: 99%

“…Similarly, the non-availability of the influenza vaccine was reported by 43% of the respondents and was associated with the failure to administer the vaccine to the patients. Notably, 33% of the HWCs feared the adverse effects of the influenza vaccine (13). There is no study done in the Northern Borders Region in the Kingdom of Saudi Arabia reviewing influenza vaccination awareness.…”

Section: Introductionmentioning

confidence: 99%

Prevalence of seasonal influenza vaccination among primary healthcare workers in Arar city, Saudi Arabia

Alenazi¹,

Hammad²,

Mohamed³

2018

Electron Physician

View full text Add to dashboard Cite

BackgroundInfluenza outbreaks occur annually and have significant ramifications on the wellbeing of the population. Influenza is given high priority in Saudi Arabia where numerous reports of different types of influenza outbreaks have occurred in recent years.ObjectiveThe study aimed to determine the prevalence of influenza vaccination among healthcare providers.MethodsThe study employed a cross-sectional design, and data was collected using a predesigned questionnaire which was validated by a panel of experts and tested for reliability (Cronbach’s alpha =0.8). All primary healthcare workers in Arar city (Saudi Arabia) were taken as a comprehensive sample between January and March 2018. The questionnaire used a Likert scale that assessed the reasons for embracing or rejecting the influenza vaccines. A p-value of ≤0.05 was considered statistically significant.ResultsIn total, 204 health professionals (72 physicians, 102 nurses and 30 other staff members) filled the questionnaire. The mean age of the healthcare professionals was 31.9±8.7 years. Self-report of seasonal influenza vaccination uptake was 55.9% (65.3% for physicians, 55.9% for nurses and 33.3% for other staff). Perceived risk of severity of influenza was 2.5 times more in the compliant group than that of the non-compliant group (p<0.001, 95% CI: 1.4–4.4).ConclusionUtilization of influenza vaccine is 55% in both nurses and physicians despite 89% of them being aware of influenza vaccination guidelines and MOH recommendations. It is needed to ensure the intensive education of healthcare providers to understand the protective value of influenza vaccine.

show abstract

La modulation de la signature transcriptomique de l’hôte infecté : une nouvelle stratégie thérapeutique dans les viroses graves ? Exemple de la grippe

et al. 2016

View full text Add to dashboard Cite

Ces dernières décennies ont été marquées par l'émergence ou la réémergence de virus responsables d'épidémies ou de pandémies plus ou moins sévères. Les stratégies préventives sont prises à défaut, et l'arsenal antiviral curatif est limité d'autant plus que les résistances virales peuvent apparaître rapidement. Par ailleurs, le développement de nouvelles molécules nécessite un délai incompatible avec la réponse rapide nécessaire lors d'une épidémie d'envergure ou d'une pandémie. C'est la raison pour laquelle de nouvelles approches thérapeutiques sont nécessaires. Un concept novateur est le repositionnement de molécules déjà sur le marché en exploitant leur capacité à inverser la réponse transcriptomique cellulaire de l'hôte infecté. En identifiant des molécules qui visent l'hôte et non le virus, cette stratégie permet d'avoir un large spectre d'action et d'être potentiellement actif sur de nouveaux variants. La mise en place de cette stratégie nécessite de caractériser les réponses cellulaires spécifiques de l'infection virale d'intérêt, de cribler in silico des molécules candidates, de les tester sur modèles cellulaires et animaux, avant d'envisager des essais cliniques chez l'homme. Nous présenterons cette démarche en prenant pour exemple l'infection grippale. Mots clés Viroses · Grippe · Transcriptome · Repositionnement de médicamentsAbstract During the last decades, emergence and reemergence of viruses were responsible for epidemic and pandemic infectious diseases, with variable degrees of severity. Current preventive strategies are not sufficient at all, and available therapeutic drugs are very limited. Indeed, genetic variations of viruses can impair the efficacy of antiviral compounds by the apparition of resistance. Moreover, current delay needed for de novo development of drugs does not allow a rapid response in case of important epidemic or pandemic events. In this context, new therapeutic approaches are necessary. An innovative concept is to repurpose already marketed compounds that can reverse the host cellular transcriptomic response to the infection. By targeting the host, these molecules exhibit a broad-spectrum activity and are potentially effective even against new emergent strains. This

show abstract

Health care professionals’ awareness of, knowledge about and attitude to influenza vaccination

Cited by 62 publications

References 14 publications

Assessment of the belief and attitudes of Iranian healthcare personnel’s toward the influenza infection and influenza vaccination

Assessment of the belief and attitudes of Iranian healthcare personnel’s toward the influenza infection and influenza vaccination

Prevalence of seasonal influenza vaccination among primary healthcare workers in Arar city, Saudi Arabia

La modulation de la signature transcriptomique de l’hôte infecté : une nouvelle stratégie thérapeutique dans les viroses graves ? Exemple de la grippe

Contact Info

Product

Resources

About